Table 6.
Univariate analyses for the prognoses of pT1N2 gastric cancer patients
| Variables | 5-year OS rate | P |
|---|---|---|
| Age (years) | 0.427 | |
| < 60 | 92.30% | |
| ≥ 60 | 80.00% | |
| Gender | 0.304 | |
| Male | 92.90% | |
| Female | 77.80% | |
| Tumor size (cm) | 0.459 | |
| ≤ 2 | 91.70% | |
| > 2 | 81.80% | |
| Tumor location | 0.555 | |
| Upper | 66.70% | |
| Middle | 85.70% | |
| Lower | 92.30% | |
| Gross type | 0.149 | |
| Ulcerated | 100% | |
| Non-ulcerated | 78.60% | |
| Degree of differentiation | 0.815 | |
| Differentiated | 83.30% | |
| Undifferentiated | 98.20% | |
| Histopathology | 0.923 | |
| Tub | 83.30% | |
| Por | 85.70% | |
| Sig | 100% | |
| Muc | 100% | |
| Examined lymph node | 0.936 | |
| Her-2 status | 0.815 | |
| Negative | 88.20% | |
| Positive | 83.30% | |
| Depth of tumor invasion | 0.491 | |
| T1a | 100% | |
| T1b | 85.00% | |
| Lymphovascular invasion | 0.147 | |
| Negative | 93.80% | |
| Positive | 71.40% | |
| Treatment after surgery | 0.528 | |
| S-1 | 81.80% | |
| Xelox | 91.70% |
Tub, tubular adenocarcinoma; Por, poorly differentiated adenocarcinoma; Sig, signet-ring cell carcinoma; Muc, mucinous adenocarcinoma; T1a, mucosal invasion; T1b, submucosal invasion; OS, overall survival.